CD8a Antibody eFluor 506 69-0088-42 from Thermo Fisher Scientific

Product Specs
ItemCD8a Antibody eFluor 506
CompanyThermo Fisher Scientific
Price Supplier Page
Catalog Number69-0088-42
Storage4°C, store in dark, DO NOT FREEZE!
Antibody TypePrimary
Storage Temperature4° C, store in dark, DO NOT FREEZE!
PurityAffinity chromatography
ReactivityHuman (Hu)
ClonalityMonoclonal
NCBI Gene AliasesLY3, CD8alpha, CD8beta, Leu2, CD8B1, p32, LEU2, Ly-3, CD8, P37, LYT3
NCBI Full Gene NameCD8 subunit beta, CD8 subunit alpha
ApplicationsFlow Cytometry (FCM)
HostMouse
CloneRPA-T8
IsotypeIgG1 kappa
TargetCD8a
FormatPBS with BSA and 0.09% sodium azide; pH 7.2
Conjugate/TageFluor™ 506
Concentration5 µL/Test
Quantity100 Tests

Add to Compare List

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) CD20 + FCRL4 + B Cells Activate CD8 + T Cells via MHC‐I Restriction in Nasopharyngeal Carcinoma Anti‐Tumor ImmunityAdvanced ScienceJanuary 8, 2026Benjian Zhang, Xiaotian Yuan, Kelei Gao, Bo You, Yaxuan Wang, Lai Meng, Zirong Chen, Shaobing Xie, Yunqing Liu, Zijian Dong, et al.Zombie NIR (BioLegend, clone 423105), CD69‐PE (Invitrogen, 12‐0699‐41), CD8‐ eFluor 506 (Invitrogen, 69‐0088‐42), CD45RO‐FITC (Invitrogen, 11‐0457‐42). 4.13 CCK‐8 Assays The medium was removed from the cell culture

(2) Protocol for isolation of tumor-derived extracellular vesicles and functional studies on human T cell subsetsSTAR protocolsJune 21, 2024Swatler J, Targońska A, Turos-Korgul L, Mosieniak G, Piwocka K.

(3) Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaquesNature communicationsApril 26, 2024Kaiser JA, Nelson CE, Liu X, Park HS, Matsuoka Y, Luongo C, Santos C, Ahlers LRH, Herbert R, Moore IN, et al.(FITC, clone FN50, Biolegend, cat# 310903, at 1:25), CD8a (eFluor 506, clone RPAT8, Thermo Fisher, cat# 69-0088-42, at 1:250), CD4 (BUV496, clone SK3, BD Biosciences, cat# 612937, at 1:13), CD95 (BUV737, clone DX2,

(4) Immune response induced by standard and fractional doses of 17DD yellow fever vaccineNPJ vaccinesMarch 8, 2024Abdala-Torres T, Campi-Azevedo AC, da Silva-Pereira RA, Dos Santos LI, Henriques PM, Costa-Rocha IA, Otta DA, Peruhype-Magalhães V, Teixeira-Carvalho A, Araújo MSS, et al.

(5) TCR ligand potency differentially impacts PD-1 inhibitory effects on diverse signaling pathwaysThe Journal of experimental medicineDecember 4, 2023Chan W, Cao YM, Zhao X, Schrom EC, Jia D, Song J, Sibener LV, Dong S, Fernandes RA, Bradfield CJ, et al.

(6) Rethinking IL-1 Antagonism in Respiratory Viral Infections: A Role for IL-1 Signaling in the Development of Antiviral T Cell ImmunityInternational journal of molecular sciencesOctober 30, 2023Van Den Eeckhout B, Ballegeer M, De Clercq J, Burg E, Saelens X, Vandekerckhove L, Gerlo S.

(7) Prostate cancer cells synergistically defend against CD8(+) T cells by secreting exosomal PD-L1Cancer medicineAugust 1, 2023Li D, Zhou X, Xu W, Chen Y, Mu C, Zhao X, Yang T, Wang G, Wei L, Ma B.

(8) Soluble NKG2D ligands impair CD8(+) T cell antitumor function dependent of NKG2D downregulation in neuroblastomaOncology lettersJuly 1, 2023Zhang Y, Luo F, Dong K.

(9) Endosialin-positive tumor-derived pericytes promote tumor progression through impeding the infiltration of CD8(+) T cells in clear cell renal cell carcinomaCancer immunology, immunotherapy : CIIJune 1, 2023Lu T, Zhang J, Lu S, Yang F, Gan L, Wu X, Song H, Liu S, Xu C, Han D, et al.

(10) PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cellsNature communicationsDecember 12, 2022Li Q, Zhang L, You W, Xu J, Dai J, Hua D, Zhang R, Yao F, Zhou S, Huang W, et al.

(11) VLA-4 suppression by senescence signals regulates meningeal immunity and leptomeningeal metastasiseLifeDecember 9, 2022Li J, Huang D, Lei B, Huang J, Yang L, Nie M, Su S, Zhao Q, Wang Y.

(12) Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeysCellDecember 8, 2022Le Nouën C, Nelson CE, Liu X, Park HS, Matsuoka Y, Luongo C, Santos C, Yang L, Herbert R, Castens A, et al.

(13) Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaquesbioRxivSeptember 7, 2022Cyril Le Le Nouën et al.,BD Biosciences,Cat #563389; RRID: AB_2738175 "Anti-human CD8a-eFluor 506, Clone RPA-T8",Thermo Fisher,Cat #69-0088-42; RRID: AB_2637468 "Anti-human IL-2-BV605, Clone MQ1–17H12",Biolegend,Cat #500332; RRID: AB_2563877 "Anti-human

(14) Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid modelsFrontiers in oncologyJanuary 1, 2022Tan D, An J, Gong M, Wang H, Li H, Meng H, Zhang C, Zhao Y, Ge X, Shi C.

(15) Multipeptide stimulated PBMCs generate T(EM)/T(CM) for adoptive cell therapy in multiple myelomaOncotargetSeptember 28, 2021Vardam-Kaur T, Pathangey LB, McCormick DJ, Bergsagel PL, Cohen PA, Gendler SJ.

(16) Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomesNature communicationsMay 21, 2021Renner K, Schwittay T, Chaabane S, Gottschling J, Müller C, Tiefenböck C, Salewski JN, Winter F, Buchtler S, Balam S, et al.

(17) Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson's diseaseNPJ Parkinson's diseaseMay 13, 2021Thome AD, Atassi F, Wang J, Faridar A, Zhao W, Thonhoff JR, Beers DR, Lai EC, Appel SH.

(18) Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivoTheranosticsJanuary 1, 2021Zhong L, Shi W, Gan L, Liu X, Huo Y, Wu P, Zhang Z, Wu T, Peng H, Huang Y, et al.

(19) Changes of immune cells in patients with hepatocellular carcinoma treated by radiofrequency ablation and hepatectomy, a pilot studyOpen life sciencesJanuary 1, 2021Yu Z, Li G, Yu H, Asakawa T.

(20) Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF InhibitionFrontiers in immunologyJanuary 1, 2021Yeku OO, Rao TD, Laster I, Kononenko A, Purdon TJ, Wang P, Cui Z, Liu H, Brentjens RJ, Spriggs D.

Be the First to Write a Review!

Flow

Flow

CD8a Antibody eFluor 506 from Thermo Fisher Scientific

Thermo Fisher Scientific

Citations (41)

Reviews

CD8a Antibody eFluor 506 from Thermo Fisher Scientific

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map